Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

0.0%

-86.6% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 4

1(25.0%)

Phase 1

1(25.0%)

4Total

N/A(2)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07631468Not Yet Recruiting

PROspect Registry :Post Market Clinical Follow-up Study

Role: lead

NCT06002906Phase 4Active Not Recruiting

The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery.

Role: collaborator

NCT06320925Recruiting

SportsPro: Post-Market Clinical Follow Up Study

Role: lead

NCT05329584Not ApplicableRecruiting

InSpace Accelerated Rehabilitation Study

Role: lead

NCT05734118Not ApplicableUnknown

Safety and Feasibility of Indocyanine Green Fluorescence for Intraoperative Assessment of Intestinal Perfusion in Young Infants and Neonates

Role: collaborator

NCT05006950Phase 1Terminated

SPY Fluorescence Imaging Systems and Indocyanine Green to Determine the Percentage of Successful Critical Anatomy Recognition in Laparoscopic Cholecystectomy Surgeries.

Role: lead

All 6 trials loaded